Echo Therapeutics, Inc. Retained Earnings
Echo Therapeutics, Inc. had Retained Earnings of -$154.90 million as of 2016-09-30, per its 10-Q filed 2016-11-16.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2016-11-16
- 2016-09-30: Retained Earnings (Accumulated Deficit) -$154.90M.
- 2016-06-30: Retained Earnings (Accumulated Deficit) -$155.69M.
- 2016-03-31: Retained Earnings (Accumulated Deficit) -$152.75M.
- 2015-12-31: Retained Earnings (Accumulated Deficit) -$150.13M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2016-09-30 | -$154.90M 10-Q · filed 2016-11-16 | |
| 2016-06-30 | -$155.69M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | -$152.75M 10-Q · filed 2016-05-20 | |
| 2015-12-31 | -$150.13M 10-Q · filed 2016-11-16 | |
| 2015-09-30 | -$148.85M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | -$147.08M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | -$136.24M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | -$127.93M 10-K · filed 2016-03-30 | |
| 2014-09-30 | -$122.19M 10-Q · filed 2015-04-20 | -$125.01M 10-Q · filed 2014-11-19 |
| 2014-06-30 | -$119.51M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | -$115.74M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | -$112.97M 10-Q · filed 2015-04-20 | |
| 2013-09-30 | -$109.47M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | -$104.23M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | -$100.89M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | -$93.90M 10-K · filed 2014-03-28 | |
| 2012-09-30 | -$91.98M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | -$87.71M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | -$84.56M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | -$81.57M 10-K · filed 2013-03-18 | |
| 2011-09-30 | -$79.45M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | -$78.08M 10-Q · filed 2011-08-12 | |
| 2010-12-31 | -$71.54M 10-K · filed 2012-03-15 |